2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow MK-8150: new trials by email Literature Review of MK-8150 trials Research Report on MK-8150
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8150 (MK-8150-002) MK-8150, Placebo for MK-8150 - Hypertension, Isolated Systolic Hypertension | Phase 1 | Completed | Merck Sharp & Dohme LLC | 103 | 2012-08-01 | 2018-09-25 |
| A Single Rising Dose Study of MK-8150 (MK-8150-001) MK-8150 2.0 mg, MK-8150 10 mg, MK-8150 40 mg - Hypertension, Isolated Systolic Hypertension (ISH) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 34 | 2012-05-07 | 2018-09-25 |
Hypertension (2) · Isolated Systolic Hypertension (2)